Extract: " We also believe that PBT-1 has the potential to be approved as a therapy in its own right. The further clinical development of PBT-1 is now being considered".
"We are now concentrating on developing new and superior MPACs : PBT-2 has since demonstrated superior performance across a range of in vitro and in vivo preclinical tests and is in the final months of toxicology testing before entering clinical trials early in 2005".
Oct. 6: Dr Bush awarded 2004 Zenith Fellow Award for Research: http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=225479
PBT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)